0.366

5.72% 0.0198

After Hours: .37 0.004 +1.09%

Reviva Pharmaceuticals Holdings Inc (RVPH)

Overview News Price History Option Chain Financials Discussions Forecast

Reviva Pharmaceuticals Holdings Inc stock is traded at $0.366, with a volume of 5.13M. It is up +5.72% in the last 24 hours and down -41.41% over the past month. Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Previous Close:

$0.3462

Open:

$0.3562

24h Volume:

5.13M

Relative Volume:

0.56

Market Cap:

$42.77M

Revenue:

Net Income/Loss:

$-27.11M

P/E Ratio:

-0.5631

EPS:

-0.65

Net Cash Flow:

$-26.55M

1W Performance:

+31.18%

1M Performance:

-41.41%

6M Performance:

-2.81%

1Y Performance:

-80.43%

1-Day Range:

$0.3401

$0.375

1-Week Range:

$0.2722

$0.375

52-Week Range:

$0.25

$2.15

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile

Name

Reviva Pharmaceuticals Holdings Inc

Sector

Healthcare (1114)

Industry

Biotechnology (621)

Phone

(408) 501-8881

Address

10080 N WOLFE ROAD, CUPERTINO

Employee

Twitter

Next Earnings Date

2025-03-31

Latest SEC Filings

RVPH's Discussions on Twitter

Compare RVPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RVPH Reviva Pharmaceuticals Holdings Inc	0.366	40.45M	0	-27.11M	-26.55M	-0.65
VRTX Vertex Pharmaceuticals Inc	469.68	122.84B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	801.01	85.37B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	399.40	55.82B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	795.57	50.67B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	170.27	37.54B	447.02M	-1.18B	-906.14M	-6.1812

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-29-25	Initiated	Chardan Capital Markets	Buy
Sep-20-23	Initiated	ROTH MKM	Buy
Jun-08-23	Initiated	The Benchmark Company	Speculative Buy
Jan-24-22	Initiated	H.C. Wainwright	Buy

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News

02:30 AM

Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock a top pick in earnings seasonQuarterly Risk Review & Community Trade Idea Sharing Platform - ulpravda.ru

02:30 AM

12:50 PM

How strong is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock revenue growth2025 Fundamental Recap & Long-Term Investment Growth Plans - ulpravda.ru

12:50 PM

11:27 AM

How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock benefits from tech adoption2025 Biggest Moves & Daily Growth Stock Investment Tips - ulpravda.ru

11:27 AM

11:23 AM

Reviva Pharmaceuticals Holdings, Inc. Announces Publication on Clinical Vocal Biomarker Data from the Recover Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia - MarketScreener

11:23 AM

10:42 AM

Aug PreEarnings: How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock benefits from tech adoption2025 Macro Impact & Weekly Chart Analysis and Trade Guides - ulpravda.ru

10:42 AM

09:52 AM

Will Reviva Pharmaceuticals Holdings Inc. stock maintain dividend yield2025 Retail Activity & Daily Profit Maximizing Trade Tips - ulpravda.ru

09:52 AM

08:00 AM

Reviva Announces Publication on Clinical Vocal Biomarker - GlobeNewswire

08:00 AM

Jan 07, 2026

Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock continue upward trendBlue Chip Stock Analysis & Free Long-Term Investment Planning - ulpravda.ru

Jan 07, 2026

Jan 06, 2026

Worth Investment Trading Company Limited Shows Risk Reward Favoring Upside - earlytimes.in

Jan 06, 2026

Jan 05, 2026

Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating - Investing.com Canada

Jan 05, 2026

Jan 02, 2026

Volatility Watch: Will Reviva Pharmaceuticals Holdings Inc Equity Warrant stock attract ESG investorsJuly 2025 Chart Watch & Verified Stock Trade Ideas - moha.gov.vn

Jan 02, 2026

Reviva Pharmaceuticals Holdings Inc Stock Analysis and ForecastMarket Timing Techniques & Explosive Trading Portfolio - earlytimes.in

Jan 02, 2026

Relief Rally in Veeram Securities Limited Stock Can It HoldVolatility Adjusted Trading & Download Our Free Trading Blueprint - earlytimes.in

Jan 02, 2026

What analysts say about Reviva Pharmaceuticals Holdings Inc stockBollinger Bands Signals & Try Our Free Strategy Builder Now - earlytimes.in

Jan 02, 2026

Jan 01, 2026

Technical Charts Suggest Momentum Shift in Sapphire Foods India LimitedEarnings Forecast Updates & Learn to Trade with Real-Time Feedback - earlytimes.in

Jan 01, 2026

Dec 29, 2025

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum - The Manila Times

Dec 29, 2025

Dec 28, 2025

Dow Gains 100 Points; US Durable Goods Orders Decline In October - Sahm

Dec 28, 2025

Dec 26, 2025